Compare GABC & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GABC | BHC |
|---|---|---|
| Founded | 1910 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 1995 | 1996 |
| Metric | GABC | BHC |
|---|---|---|
| Price | $50.41 | $6.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $47.67 | $8.00 |
| AVG Volume (30 Days) | 146.8K | ★ 4.6M |
| Earning Date | 04-27-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | 8.13 | ★ 423.08 |
| EPS | ★ 1.90 | N/A |
| Revenue | $487,401,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $16.78 | $4.61 |
| Revenue Next Year | $3.98 | N/A |
| P/E Ratio | $57.72 | ★ N/A |
| Revenue Growth | ★ 37.80 | N/A |
| 52 Week Low | $37.19 | $4.33 |
| 52 Week High | $52.23 | $8.69 |
| Indicator | GABC | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 66.00 | 58.46 |
| Support Level | $38.49 | $5.89 |
| Resistance Level | $52.23 | $6.31 |
| Average True Range (ATR) | 0.91 | 0.41 |
| MACD | 0.09 | 0.18 |
| Stochastic Oscillator | 74.33 | 53.20 |
German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.